Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |